Clinical Trial Update: Evaluate the Efficacy of AMG 706 to Treat Advanced Gastrointestinal Stromal Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating AMG 706 (motesanib) for advanced gastrointestinal stromal tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Drugs mentioned

• AMG 706 (motesanib)

Snippet

Sponsor: Amgen | Conditions: Advanced Gastrointestinal Stromal Tumor | Phase 2 | Status: COMPLETED